| Targeting the disordered C terminus of PTP1B with an allosteric inhibitor N Krishnan, D Koveal, DH Miller, B Xue, SD Akshinthala, J Kragelj, ... Nature chemical biology 10 (7), 558-566, 2014 | 355 | 2014 |
| Loss of Par3 promotes breast cancer metastasis by compromising cell–cell cohesion B Xue, K Krishnamurthy, DC Allred, SK Muthuswamy Nature cell biology 15 (2), 189-200, 2013 | 191 | 2013 |
| Hsp70 inhibits lipopolysaccharide-induced NF-κB activation by interacting with TRAF6 and inhibiting its ubiquitination H Chen, Y Wu, Y Zhang, L Jin, L Luo, B Xue, C Lu, X Zhang, Z Yin FEBS letters 580 (13), 3145-3152, 2006 | 181 | 2006 |
| Cell polarity as a regulator of cancer cell behavior plasticity SK Muthuswamy, B Xue Annual review of cell and developmental biology 28, 599-625, 2012 | 156 | 2012 |
| Rotational motion during three-dimensional morphogenesis of mammary epithelial acini relates to laminin matrix assembly H Wang, S Lacoche, L Huang, B Xue, SK Muthuswamy Proceedings of the National Academy of Sciences 110 (1), 163-168, 2013 | 151 | 2013 |
| G-protein–coupled receptor GPR161 is overexpressed in breast cancer and is a promoter of cell proliferation and invasion ME Feigin, B Xue, MC Hammell, SK Muthuswamy Proceedings of the National Academy of Sciences 111 (11), 4191-4196, 2014 | 95 | 2014 |
| Regulation of lipopolysaccharide-induced inflammatory response by glutathione S-transferase P1 in RAW264. 7 cells B Xue, Y Wu, Z Yin, H Zhang, S Sun, T Yi, L Luo FEBS letters 579 (19), 4081-4087, 2005 | 78 | 2005 |
| Recombinant protein glutathione S-transferases P1 attenuates inflammation in mice L Luo, Y Wang, Q Feng, H Zhang, B Xue, J Shen, Y Ye, X Han, H Ma, J Xu, ... Molecular immunology 46 (5), 848-857, 2009 | 54 | 2009 |
| A novel role for 14–3–3σ in regulating epithelial cell polarity C Ling, D Zuo, B Xue, S Muthuswamy, WJ Muller Genes & development 24 (9), 947-956, 2010 | 52 | 2010 |
| Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation M Yu, G Lin, N Arshadi, I Kalatskaya, B Xue, S Haider, F Nguyen, ... Molecular and cellular biology, 2012 | 48 | 2012 |
| The signaling adaptor GAB1 regulates cell polarity by acting as a PAR protein scaffold Z Yang, B Xue, M Umitsu, M Ikura, SK Muthuswamy, BG Neel Molecular cell 47 (3), 469-483, 2012 | 41 | 2012 |
| miR-200 deficiency promotes lung cancer metastasis by activating Notch signaling in cancer-associated fibroblasts B Xue, CH Chuang, HM Prosser, CS Fuziwara, C Chan, N Sahasrabudhe, ... Genes & development 35 (15-16), 1109-1122, 2021 | 39 | 2021 |
| An expanding universe of the non-coding genome in cancer biology B Xue, L He Carcinogenesis 35 (6), 1209-1216, 2014 | 39 | 2014 |
| A Novel Hydrogel-Based 3D In Vitro Tumor Panel of 30 PDX Models Incorporates Tumor, Stromal and Immune Cell Compartments of the TME for the Screening of Oncology and Immuno … B Xue, J Schüler, CM Harrod, K Lashuk, Z Bomya, KC Hribar Cells 12 (8), 1145, 2023 | 2 | 2023 |
| Abstract A236: The orphan G-protein coupled receptor GPR161 is an oncogene in triple negative breast cancer. ME Feigin, B Xue, M Hammell, SK Muthuswamy Molecular Cancer Therapeutics 12 (11_Supplement), A236-A236, 2013 | 1 | 2013 |
| Automated 42 PDX 3D in vitro tumor models of the TME screen immuno-oncology and targeted compounds and biologics for antitumor effects and MOA B Xue, C Harrod, L Le, J Schueler, KC Hribar Cancer Research 84 (6_Supplement), 4703-4703, 2024 | | 2024 |
| 842 High-throughput screening of cancer immunotherapy combinations using a hydrogel-based 3D in vitro tumor platform B Xue, J Schüler, C Harrod, K Hribar Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| KRAS, BRAF, BRCA1 and EGFR mutation-specific panels using hydrogel-based 3D in vitro tumor models B Xue, J Schüler, C Harrod, Z Bomya, KC Hribar Cancer Research 83 (7_Supplement), 1722-1722, 2023 | | 2023 |
| 299 3D in vitro tumor microenvironment models for screening CAR-T cell therapy efficacy B Xue, S Vermond, U Herbrand, D Harris, G Moiset, K Hribar, J Schuler Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| 1447 A 30 PDX panel of 3D in vitro tumor models identifies responders to pembrolizumab and solitomab K Hribar, B Xue, C Harrod, J Schuler Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
